{
 "drug": "Vancomycin Hydrochloride Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "09/09/2025",
 "dayN": 350,
 "cat": "Anti-Infective",
 "companies": [
  "Hospira, Inc., a Pfizer Company"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "09/09/2025",
   "update_type": "New",
   "initial_posting_date": "09/09/2025",
   "package_ndc": "0409-6531-01",
   "generic_name": "Vancomycin Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA062912"
    ],
    "brand_name": [
     "VANCOMYCIN HYDROCHLORIDE"
    ],
    "generic_name": [
     "VANCOMYCIN HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-6531",
     "0409-6533",
     "0409-4332",
     "0409-3515"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "VANCOMYCIN HYDROCHLORIDE"
    ],
    "rxcui": [
     "1807513",
     "1807516",
     "1807518",
     "2049890"
    ],
    "spl_id": [
     "10032a19-0373-4c42-b785-f3d915614e30"
    ],
    "spl_set_id": [
     "f2901045-904f-47bd-74a1-c561facd7f25"
    ],
    "package_ndc": [
     "0409-6531-12",
     "0409-6531-02",
     "0409-6533-11",
     "0409-6533-01",
     "0409-6533-21",
     "0409-4332-11",
     "0409-4332-01",
     "0409-3515-11",
     "0409-3515-01"
    ],
    "unii": [
     "71WO621TJD"
    ]
   },
   "update_date": "09/09/2025",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Vancomycin Hydrochloride, Injection, 750 mg Single Dose ADD-Vantage® Glass Vial (NDC 0409-6531-01)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "09/09/2025",
   "update_type": "New",
   "initial_posting_date": "09/09/2025",
   "package_ndc": "0409-6535-01",
   "generic_name": "Vancomycin Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "09/09/2025",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Vancomycin Hydrochloride, Injection, 1 g Single Dose ADD-Vantage® Glass Vial (NDC 0409-6535-01)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "11/14/2025",
   "update_type": "New",
   "initial_posting_date": "11/14/2025",
   "package_ndc": "0409-5017-01",
   "generic_name": "Vancomycin Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "11/14/2025",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Vancomycin Hydrochloride, Injection, 10 g Vial NovaPlus (NDC 0409-5017-01)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "To Be Discontinued"
  }
 ]
}